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Abstract 
Bisphenol A (BPA or 4,4’-(propane-2,2-diyl)diphenol) is a chemical intermediate in the 
production of polycarbonate and epoxy resins, and used in a wide range of applications. BPA 
has attracted significant attention in the past decade due to its frequency of detection in 
human populations worldwide, demonstrated animal toxicity and potential impact on human 
health, particularly during critical periods of development. The aim of this study was to 
perform a preliminary assessment of age-related trends in urinary concentration and to 
estimate daily excretion of BPA in Australian children (aged (>0 – <5 years) and adults (≥15 
– <75 years). This was achieved using 79 samples pooled by age and gender, created from 
868 individual samples of convenience collected as part of routine, community-based 
pathology testing. Total BPA was analyzed using online-SPE-LC-MS/MS and detected in all 
samples with a range of 0.65 – 265 ng/ml. No significant differences were observed between 
males and females. A urine flow model was constructed from published values and used to 
provide an estimate of daily excretion per unit bodyweight for each pooled sample. The daily 
excretion estimates ranged from 26.2 – 18200 ng/kg-d for children; and 20.1 – 165 ng/kg-d 
for adults. Urinary concentrations and estimated excretion rates were inversely associated 
with age, and estimated daily excretion rates in infants and young children were significantly 
higher than in adults (geometric mean: 107 and 47.0 ng/kg-d, respectively). Higher excretion 
of BPA in children may be explained by their higher food consumption relative to body 
weight compared to adults and adolescents, and may also reflect alternative exposure 
pathways and sources. 
 
Keywords: bisphenol A, biomonitoring, children, urine flow, Australia  
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Introduction 
Bisphenol A (BPA or 4,4’-(propane-2,2-diyl)diphenol) has attracted significant attention in 
the past decade due to its ubiquitous nature, demonstrated animal toxicity, and frequency of 
detection in human populations worldwide. BPA is a chemical intermediate in the production 
of polycarbonate and epoxy resins, and used in a wide range of applications, including food-
contact items (Brede et al. 2003, Kang et al. 2003, Sun et al. 2000, Tan and Mustafa 2003), 
insulation, building materials and thermal paper (Staples et al. 1998). Human exposure may 
occur through the un-reacted monomer in the polymer, or from remobilized BPA from the 
final product (Koch and Calafat 2009), with oral exposure identified as the most common 
route of exposure (Von Goetz et al. 2010). BPA is rapidly absorbed by the intestine; 
metabolized via first pass metabolism and excreted in the urine and feces, with a half-life 
(t1/2) of 4 – 6 hr and near-complete urinary excretion within 24 hr (Brock et al. 2001, Kim et 
al. 2003, Mahalingaihah et al. 2008, Shin et al. 2010, Volkel et al. 2002). Metabolism in 
adults occurs primarily via glucuronidation, and excretion in urine occurs overwhelmingly as 
the glucuronide (Teeguarden et al. 2011, Volkel et al. 2002).  
 
Despite the plethora of studies on BPA, the scientific community remains divided as to the 
toxicity and health effects following chronic low dose exposure (Hengstler et al. 2011, 
Talsness et al. 2009, Vandenberg et al. 2007, Willhite et al. 2008). The number of human 
epidemiological studies is limited (Robledo et al. 2013), but measures of BPA exposure have 
been associated with a range of adverse health outcomes, including behavioral effects (Braun 
et al. 2009), disruption of endocrine function (Meeker et al. 2010), obesity and insulin 
resistance (Ning et al. 2011, Wang et al. 2012), coronary heart disease (Melzer et al. 2012), 
and reproductive structure and function in both males and females (Hiroi et al. 2004, Li et al. 
2011, Sugiura-Ogasawara et al. 2005, Takeuchi et al. 2004).  
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There is general concern about environmental chemical exposures and the impact these may 
have on human health, but this is particularly important for vulnerable populations such as 
infants and children during critical periods of development. The concern is that children 
experience quantitatively and qualitatively different exposures to chemicals than adults, and 
that children have differing sensitivity to chemicals than adults, due to differences in 
behaviors and/or physiology (Scheuplein et al. 2002, Tulve et al. 2002, Volkel et al. 2008, 
World Health Organisation 2011, Xue et al. 2007). Research on developmental effects in 
human populations is challenging due to the difficulties inherent to research involving 
children, including obtaining parental consent, sampling limitations, and the need for long-
term follow-up for detection of subtle health endpoints of interest.    
 
To our knowledge there have been no apparent studies on BPA exposure in infants and young 
children in Australia, with only one recent study by Callan et al. (2012) on BPA in pregnant 
women in Australia. To date, BPA exposure in the Australian population remains largely 
uncharacterized. The number of human biomonitoring studies on BPA is steadily increasing, 
but the overwhelming majority of these focuses on adults and/or older children (e.g. Calafat 
et al. (2009), Kasper-Sonnenberg et al. (2012)). The aim of this study was to (1) conduct a 
preliminary investigation of BPA in urine collected from Australian infants and young 
children using samples of convenience, and compare this with concentrations in adults; and 
(2) provide an estimate of BPA exposure (extrapolated from urinary BPA excretion) in the 
Australian population with a particular emphasis on infants and young children.  
 
Materials and methods 
Study population and sample collection: 
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De-identified urine specimens were obtained from a community-based pathology lab 
(Sullivan Nicolaides Pathology, Taringa, QLD, Australia) from surplus stored urine that had 
been collected and analyzed as part of routine testing. Urine specimens were collected in 
sterile polyethylene urine specimen containers according to directions from the health 
physician initiating the test. Specimens were refrigerated immediately following collection 
and sent to the pathology lab for testing within 12 hr, where they were stored in monitored 
cold rooms for up to three days. Specimens were frozen immediately following collection by 
researchers. As this was a pre-existing, convenience population no specific sampling 
protocols were employed. Urine specimens were collected and pooled between November 
2010 and March 2011 for children, and March to April 2011 for adults. All samples were 
analyzed June to July 2011. This study was approved by the University of Queensland ethics 
committee (approval number 2002000656). 
 
Pooling protocol: 
Descriptive information about each specimen was limited to date of birth, date of sample 
collection and gender. Before pooling, samples were stratified according to age and gender. 
Specimens were pooled based on volume, where each individual in the pool contributed the 
same volume to the pool (e.g. 7 individual specimens of 1 ml each combined to give a pooled 
sample with total volume of 7 ml). During pooling, individual urine specimens were thawed, 
homogenized and aliquoted into amber glass bottles. The pooled sample was homogenized 
before being divided into smaller aliquots stored in 2 ml amber glass vials and frozen until 
analysis. No measures of creatinine or specific gravity were available. 
 
For children the age strata were: >0 – <0.5; ≥0.5 – <1; ≥1 – <1.5; ≥1.5 – <2; ≥2 – <2.5; ≥2.5 
– <3; ≥3 – <3.5; ≥3.5 – <4; ≥4 – <4.5; and ≥4.5 – <5 years (448 individual samples were 
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collected and combined into 64 pools, where each pool contained 7 individual samples). For 
adults, age strata were: ≥15 – <30; ≥30 – <45; ≥45 – <60 and ≥60 – <75 years (420 
individual samples were collected and combined into 15 pools, where each pool contained 28 
individual samples). The mean age of each pool was calculated from the average age of the 
individuals making up that pool. Replicate pools per strata were constructed where sufficient 
samples were available. The concentration of BPA measured in each pool is equivalent to the 
arithmetic mean of the concentration of BPA in each individual sample contributing to the 
pool (Caudill 2010, Mary-Huard 2007).  
 
Analysis: 
Pooled samples were analyzed for total BPA (free plus conjugated species, henceforth 
referred to as ‘BPA’) using a modified method described previously by Ye et al. (2005). 
Briefly, 100µl urine was diluted to 1ml (pH 5), deconjugated using β-glucuronidase (Helix 
pomatia H1) and incubated at 37°C overnight. Samples were injected directly using a GX-
271 liquid handler, and analyzed using online solid phase extraction (SPE) using an Alltima 
HP C18 7.5 × 3.00 mm, 5 μm cartridge (Grace). The liquid chromatography tandem mass 
spectrometry (LC-MS/MS) systems consisted of a Shimadzu Prominence UFLC system 
coupled to an AB Sciex API 5500 QTRAP equipped with an APCI (atmospheric pressure 
chemical ionisation) source. Chromatographic separation was achieved using a Syneri Fusion 
50 × 2.00 mm, 2.5 μm column (Phenomenex). Quantitation was performed by isotope 
dilution using 13C-BPA (Cambridge Isotope Laboratories). Method repeatability and 
reproducibility were good (%RSD <10%). 
 
Quality control procedures 
Page 8 
 
A quality control sample of pooled adult urine of known concentration (2.35 ± 0.26 ng/ml, 
n=14) was analyzed with each batch of samples to monitor instrument performance. Potential 
background contamination from lab procedures and reagents was monitored by substituting 
ultrapure water for urine, and extracting in the same manner as an unknown urine sample. 
The background BPA was low and consistent across batches (0.085± 0.016 ng/ml, n=20).  
 
The limit of detection (LOD) was 0.05ng.ml (calculated as 3*standard deviation of the 
blank), but as the blank levels were significantly higher than this value, the limit of reporting 
(LOR) was calculated as 3*average blank, and set as 0.3 ng/ml. 97% of samples had a 
concentration ≥10 times the concentration of the blank, and 88% of samples had a 
concentration ≥5 times the limit of reporting. No blank subtraction was performed.  
 
Urine flow model and daily excretion estimates:    
Urinary flow data and accompanying demographic and bodyweight data were downloaded 
from the U.S. National Health and Nutrition Examination Survey (NHANES) 2009-2010 
survey cycle (CDC 2012). Participants in the survey were asked the time since previous 
urinary void and urinary void volume was recorded when the urine sample was collected. 
Daily urinary flow per kilogram (kg) bodyweight was calculated for each participant in the 
survey by extrapolating the collected volume to a full 24-hr time period and dividing by the 
recorded bodyweight. The arithmetic mean of bodyweight-adjusted urinary flows were 
calculated using appropriate population weighting factors from the NHANES dataset for each 
age (≥6 years) and gender group represented by a urine pool sample. Since the NHANES data 
set was limited to individuals ≥6 years, urinary flow data for infants and children (<15 years) 
were identified from other sources in the literature (Ballauff et al. 1988, Ebner and Manz 
2002, Goellner et al. 1981, Magos 1987, Maguire et al. 2007, Martins et al. 2011, Pratt et al. 
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1948, Roberts and Lucas 1985), and normalized to ml/kg-d in a similar manner as described 
above (refer to Supplementary Material for more information). This approach relies upon an 
assumption that urinary flow in Australian subjects is similar to that observed in the datasets 
reported in the literature and in the NHANES program. 
 
Daily urinary excretion of BPA on a per kg bodyweight basis, E (ng/kg-d), was calculated for 
each pool using the model-predicted, age-specific urinary flow, F ( ml/kg-d), and measured 
pool concentrations, C (ng/ml): 
 
E = F * C     (1) 
 
This approach explicitly assumes that the BPA urinary excretion rate during the time period 
covered by the urinary void sampled is consistent over a 24 hr period. This is almost certainly 
not the case for an individual spot sample given the rapid elimination kinetics of BPA (Ye et 
al. 2011). However, in this study, the use of pooled samples mitigates the impact of the rapid 
elimination kinetics on urinary concentrations and elimination rates, to some extent, since the 
sampling from different individuals included in the pooled sample likely occurred at different 
intervals following last BPA exposure. 
 
Statistical analysis 
The influence of age (in years) and gender was assessed via linear regression on ln-
transformed urinary concentration or excretion estimates. All analyses were conducted using 
GraphPad Prism, version 5.03 for Windows, (GraphPad Software, San Diego California, 
USA, www.graphpad.com). Criteria for significance was set as p<0.05. Urinary 
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concentrations and excretion estimates were modelled as follows in a weighted regression 
(with each pool result weighted by the number of individuals included in the pool): 
 
Ln(concentration or excretion) = I + β1*Age +  β2*Gender    (2) 
 
Results 
Urinary concentrations of BPA 
BPA was detected in 100% of the 79 pooled samples with total BPA concentration ranging 
from 0.65 – 265 ng/ml. The geometric mean (GM) was 2.97 and 2.61 ng/ml, for 
infants/young children (>0 – <5 years), and adults (≥15 – <75 years), respectively (Table 1, 
and further, Supplementary Material). There were no significant differences observed 
between BPA concentrations in males and females >0 – <5 years. Gender was also not 
significant for adults and was omitted from the final regression model. 
 
The dataset contained three extreme values (identified by visual inspection; see Figure 2a), 
one in each of the ≥0.5 – <1 year male, ≥1 – <2 year male and ≥4 – <5 year female categories 
at 265, 37.8 and 30.5 ng/ml, respectively. These samples were re-extracted and re-analyzed to 
ensure that measurement error was not the source of variation; similar results were obtained 
for replicate analyses. Although these samples showed high concentrations, they are not 
unreasonably high, with similar values reported previously in studies analyzing individual 
spot urine samples in children (Braun et al. 2011, Morgan et al. 2011).  
 
Urinary flow model and BPA excretion estimates 
Infants have a lower capacity to filter and concentrate urine (Aperia et al. 1984). A urine flow 
model was developed to provide an age-specific estimate of average urine flow, adjusted to 
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bodyweight. A search was undertaken, limited to studies with no intervention (e.g. no dietary 
intervention), and assessing children between the ages of 1 week and 15 years. Measurements 
in the first week of life were excluded to avoid instability in the immediate postnatal period. 
There was a large amount of variation in the daily urine volumes reported, particularly for 
infants. For instance, Magos (1987) suggests that urine flow is relatively consistent between 
different ages, whereas a number of other authors (Goellner et al. 1981, Pratt et al. 1948, 
Roberts and Lucas 1985) reported substantially higher values for infants <6 months. The 
discrepancy is most likely due to the difficulties in obtaining accurate and complete urine 
samples from infants and young children (e.g. lack of toilet training). As such, there is a large 
degree of uncertainty in these measurements, and so the results of the model need to be 
interpreted accordingly. Estimates of average daily flow for older adolescents and adults 
plateau at approximately 18 ml/kg-d (based on NHANES data for adults; data not shown).  
Figure 1 presents the urinary flow model, based on a fit to the available datasets without 
weighting using an exponential decay curve constrained to plateau at 18 ml/kg-d (for more 
information see Supplementary Material).   
 
The estimated urinary BPA excretion per kg body weight per day was calculated using 
equation (1) for each pool, and the results are presented in Table 1. The results ranged from 
26.2 – 18200 ng/kg-d for infants/young children (>0 – <5 years), and 20.1 – 165 ng/kg-d for 
adults (≥15 – <75 years), with significantly higher GM in infants compared to adults (107 and 
47 ng/kg-d, respectively). Since the 24 hr urine volumes used in the model were not gender 
specific, the model cannot be used to comment on potential gender differences in BPA 
excretion in any age group.  
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Under a steady-state assumption, daily urinary excretion of BPA will be equal to daily intake 
(Volkel et al. 2002). Thus, although there are sources of variability and uncertainty in the 
estimates presented here (see below for more discussion), the estimated daily excretion of 
BPA in this study can be taken as estimates of daily BPA intake in the population covered by 
this study. 
 
The results of the weighted regressions are reported in Table 2. Weighted (by pool size) 
linear regression of log-transformed urinary concentrations showed a significant negative 
trend with age (Figure 2a); the association remained significant even after omission of the 
three influential data points identified above. Regression of the daily excretion estimates also 
indicates that BPA excretion (ng/kg-d) fell with increasing age (Figure 2b). Thus, for infants 
estimated daily BPA excretion is more than 4-fold higher than estimates based on the pools 
from the oldest adult age groups (113 ng/kg-d and 26.8 ng/kg-d, respectively). The negative 
relationship remains even when the influential data points are excluded. The strong negative 
trend in the estimated excretion rates (Figure 2b) is dominated by the age trend in the urinary 
flow model. Additional data on BPA concentration and excretion rates across the entire age 
range of the population would allow for further exploration.     
 
Discussion 
This study provides the first analysis of urinary concentrations of BPA in Australian infants 
and young children with comparable data for adults. The use of pooled urine samples 
provides estimates of the arithmetic mean BPA concentrations in the underlying urine 
samples, and the analysis of multiple pools across various age groups provides the first 
indication of an age trend for BPA concentration and estimated excretion in the Australian 
population. These data can be used as a baseline for future studies. In addition, the tabulation 
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of urinary flow for infants and children presented here should prove useful for researchers 
studying biomarker concentrations in urine, since the variation with age of urinary flow 
indicates that daily exposure and excretion rates of compounds excreted in urine differ across 
age, even when the measured concentrations are similar. This indicates that volume-based 
measures of concentration for environmental chemicals may significantly underestimate 
actual exposures for young age groups relative to older age groups, and impact of the high 
degree of variability in urinary flow estimates for the younger ages need to be taken into 
account. 
 
The age trend reported here for BPA, with somewhat higher urinary concentrations and much 
higher excretion estimates in infants and young children compared to adults, is consistent 
with known differences in environmental contact rates. Children have higher food 
consumption relative to body weight compared to adults and adolescents (EPA 2011). The 
average estimated urinary BPA excretion in this study for ≥1 – <2 and ≥2 – <3 years were 
219 and 105 ng/kg-d, compared to 47 ng/kg-d in adults. These differences are consistent with 
the magnitude of the increase in food intake (relative to body weight), which for children 
aged 1 – 3 years are, on average 3-4-fold higher than adults (EPA 2011).   
 
Free species and background contamination 
Quantification of both free and total BPA in urine is not performed routinely in 
biomonitoring studies relying on urine, for example, NHANES (Calafat et al. 2008) and 
Canadian Health Measures Survey (Bushnik et al. 2010). Those studies examining free BPA 
find it rarely; for instance, Volkel et al. (2011) only found quantifiable levels of free BPA in 
3% of samples. Measurement of free BPA in urine provides little information of the amount 
of free BPA available in potential target tissues. In general, measurement of total BPA in 
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urine is useful primarily as a biomarker of external exposure, not as a biomarker of target 
tissue dose of free BPA, and it is in this context that data were presented in this study.   
 
The challenge when analyzing ubiquitous chemicals such as BPA is that external 
contamination during handling and analysis may adversely affect the results. To minimize 
potential contamination strict quality assurance procedures were applied, as suggested by Ye 
et al. (2013), including: (1) avoidance of plastic apparatus where possible and the use of a 
‘clean’ lab where practical; (2) assessment of reagent and procedural blanks and the use of in-
line filters to limit contamination by mobile phases;  (3) analysis of matrix-matched quality 
control samples with each batch; and (4) replicate analyzes within and across batches.  
 
As this was a convenience population and sample collection was not orchestrated, it was not 
possible to standardize collection procedures or collect field blanks. A study was conducted 
to investigate the possibility of pooling error, whereby potential contamination from lab 
apparatus etc. was compounded because several specimens were combined to create a single 
pooled sample; and potential contamination by pathology storage conditions. There was no 
discernible difference between samples collected, pooled and stored for 7 days in standard 
polyethylene urine specimen jars (n=9) and those stored in amber glass bottles (n=9). Further, 
BPA concentration of pools (n=6) created from 1, 7 or 14 individual specimens were 
comparable to the levels in an ultrapure water blank (n=4). It was concluded that the storage 
conditions and the pooling procedure did not contribute significantly to the background 
contamination present in all samples. Further, analytical blanks substituting ultra-pure water 
for urine were extracted and analyzed with each batch of samples, and showed low and 
consistent levels of BPA. This was attributed to trace contamination of mobile phases and 
possible leaching from the analytical equipment.  
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Comparisons to other studies 
Although the importance of childhood exposures is recognized, there is a lack of exposure 
data for children, particularly for infants. A comprehensive review of all biomonitoring data 
for BPA in all populations is beyond the scope of this paper. In a review of the literature for 
urinary BPA concentrations in infants and young children <5 years, only 4 studies were 
identified (Table 3). An additional study by Calafat et al. (2009) assessed BPA exposure in 
preterm infants. However, because of the significant medical intervention in this population, 
the results are not likely to reflect routine exposures for the broader population, so this study 
was excluded. Kasper-Sonnenberg et al. (2012) reported on urinary BPA concentrations in 
somewhat older children in Germany (ages 6 to 8), and the results of the most comprehensive 
cross-sectional study of urinary BPA in US children ages 6 and above are available through 
the US NHANES program (Calafat et al. 2008). 
 
While the studies on infants and children under age 6 provide insight into an otherwise 
largely unexplored area of urinary biomonitoring, some studies have a limited sample size 
(Casas et al. 2011, Volkel et al. 2008), or range of participants (Volkel et al. 2011). However, 
these studies can be used to provide a comparison point for baseline Australian data; and the 
high detection frequency and range reported in this study is consistent with similar 
populations in other developed countries (Table 3).  
 
As discussed above, because BPA is rapidly and almost entirely excreted in urine, the daily 
excretion estimates presented here (Table 1) can be used as an estimate of average daily 
intake of BPA for each pool strata. Two additional studies were identified that provided 
excretion estimates for their study populations, which were then presumed to represent intake 
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levels. In a study of 2 – 5 year olds (n=257), Morgan et al. (2011) calculates a maximum 
aggregate total intake dose of 4.7 μg/kg-d (based on maximum urinary concentration of 211 
ng/ml) and compare it to the Tolerable Daily Intake (TDI) of 50 µg/kg-d set by the European 
Food Safety Authority (EFSA 2006). However, the daily urine excretion rate used (i.e. daily 
urine flow per unit body weight, 22.4 ml/kg) is significantly lower than the values predicted 
in our model. The use of the higher urine flow modelled here for young children might result 
in a similar estimate of maximum daily BPA excretion.  
 
Similarly, Volkel et al. (2011) provides a risk assessment for BPA exposure based on free 
and total BPA in infants aged 1 – 5 months. Margins between estimated intakes and the TDI 
(for total BPA) were calculated using two methods, and the authors report estimated intakes 
18- and 64-fold lower than the TDI (for the maximum urinary concentration of 17.85 ng/ml). 
The measured urinary BPA concentrations in Volkel et al. (2011) study were lower than the 
concentrations measured in many pools in the current study. However, all estimated excretion 
rates in this study were less than 1 µg/kg-d, and for ages 3 and above, were less than 0.1 
µg/kg-d, which is well below the current EFSA TDI of 50 µg/kg-d. In a more recent risk 
assessment for BPA, Willhite et al. (2008) recommended an oral reference dose (RfD) of 16 
µg/kg-d. Again, estimated daily exposure rates based upon the urinary excretion estimates in 
this study were all below this value. 
 
Limitations and sources of uncertainty 
Study population and the use of pooled samples 
The samples were sourced from a community-based pathology lab, and the health status of 
the patients was unknown. The individual pathology specimens collected were a convenience 
sample, and not statistically representative of the general Australian population. In order to 
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evaluate the use of pathology samples for this study a random selection of pathology samples 
(n= 205) was examined to assess the proportion of the study population with the potential for 
abnormal results. In children 0-5 years (n=205) 95% had normal pathology results and 5% 
reported evidence of a urinary tract infection. However, due to the large number of 
individuals represented by the pooled samples, there is little reason to expect a specific 
systematic bias in the pooled sample concentrations overall, compared to the general 
population.  
 
Pooled samples can be used to monitor levels of exposure and identify exposure trends in a 
population, with significant reduction in time and resource requirements. The goal of the 
study was to provide initial estimates of central tendency of BPA exposure levels in the 
Australian population by utilizing convenience samples of urine, because no relevant data on 
BPA exposure was previously published. The pooling procedure employed allowed 
accomplishment of this initial goal with the limited resources available. 
 
Pooled samples provide no reliable information on population variance, but the central 
tendencies of exposure represented by pooled samples presented in this study may provide 
information that is relevant to assessment of general population exposure levels in the 
broader Australian population. These data can inform decisions regarding allocation of 
additional resources to a more comprehensive and representative study of the Australian 
population, including an assessment of population variation.  
 
Uncertainty in excretion estimates 
Infants and young children in this study had significantly higher estimated daily urinary 
excretion of BPA than adults. Based on the rapid and complete absorption and elimination of 
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BPA in humans, this suggests that daily exposure is also higher in infants and children than 
adults. Daily excretion estimates need to be interpreted with caution, as there is a significant 
degree of uncertainty in the values used to perform these calculations (e.g. 24 hr urine 
volume), especially for very young children. Additional sources of variability and uncertainty 
include temporal variation attributable to the short elimination half-life of BPA and 
limitations associated with the urine specimens used in this study. 
 
Half-life and the use of spot samples 
The short t1/2 of BPA means that urinary concentrations reflect relatively recent exposures, 
and there is likely to be a large degree of within- and between-individual variability in spot 
urine sample concentrations for short t1/2 chemicals (Aylward et al. 2012). Ye et al. (2011) 
found that during a 7 day sampling period, urinary BPA concentrations varied by more than 
an order of magnitude within an individual, and within-day variance accounted for 70% of 
total variation in spot sample concentrations, which outweighed the between-person (9%) and 
between-day and within-person (21%) variances. This suggests intermittent exposure, with a 
significant increase in urinary concentration within a few hours of exposure, and rapid 
decline until the next exposure event; and indicates that the time of sample collection (for 
example, directly following exposure compared to several hours afterwards), may strongly 
impact on the urinary concentration for any given individual. As BPA exposure is largely 
associated with oral exposure from food-contact items (Von Goetz et al. 2010), where the 
patterns of exposure depend on frequency of use, dietary habits etc., it is reasonable to expect 
urinary concentration to be higher following consumption of BPA-contaminated food. It 
should be noted here that non-dietary ingestion could be an important route of exposure for 
infants and young children with frequent hand-to-mouth activity. Although the use of pooled 
samples from different individuals is likely to reduce the concentration variation associated 
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with within-individual temporal variability, such variability might still influence the pool 
concentration. This is particularly true for the >0 – <0.5 year pools, where only 7 individuals 
contributed to the pool. If one or two individuals were sampled shortly following an elevated 
exposure, then the pool mean might also be elevated compared to typical levels for the age 
group.  
 
Concentration adjustments 
Ye et al. (2011) also noted a significant difference in the variation for urinary concentrations 
versus creatinine-corrected concentrations, suggesting that hydration status is an important 
influence on variance. Thus, for an individual with lower hydration status and lower urine 
volume, concentrations reported on a volume basis are higher than those corrected for 
hydration. Use of creatinine adjustment to address variations in hydration status in infants and 
children for comparisons with adults is complicated by the non-linear, highly age-dependent 
pattern of creatinine excretion rates in children, as well as due to the influence of other 
parameters on creatinine excretion rates (Barr et al. 2005, Remer et al. 2002). No creatinine 
or specific gravity data were available for the samples used in this study. However, for the 
interpretation of pooled measurements as representative measures of average concentration, 
variation in individual sample hydration status is expected to be averaged out and not 
introduce significant bias to the estimated average concentrations and excretion rates.  
 
Higher concentrations of BPA in children may be explained by their higher food 
consumption relative to body weight when compared to adults and adolescents. Alternatively, 
this may be explained by differences in exposure or metabolism (Hengstler et al. 2011) of 
BPA, particularly for infants and neonates, respectively. Despite extensive research on BPA, 
the scientific community remains divided on the population-wide health effects of chronic 
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low dose exposure. Considering that BPA is ubiquitous in all ages in developed countries 
across the world; that the highest levels are found in infants and children; and that infants and 
young children may be particularly susceptible to hormonally-active compounds during 
critical periods of development; additional effort needs to be directed to improving 
knowledge gaps in early-life exposures, with the ultimate aim of reducing exposure.  
 
Conclusions 
This study presents the first data on urinary concentrations of BPA in Australian infants and 
young children. Although there are significant within-individual variations in urinary 
concentration of BPA, the impact of this intra-individual variation may be reduced by using 
pooled samples. Concentrations based on pooled, single spot samples, such as in this study, 
may be useful in providing population-wide estimates of urinary concentrations in large 
cross-sectional studies, which can then be compared to other populations. Further, pooled 
samples allow for a greater number of individual specimens to be analyzed in a timely and 
cost effective manner compared with individual specimen analysis. The use of a urine flow 
model allowed for the estimation of average daily excretion per unit body weight, which was 
found to be significantly higher in children than adults, even though urinary concentrations 
were similar. This may be explained by differences in behavior, exposure, or metabolism; or 
a combination of these factors. A comprehensive sampling strategy with more data points, 
and a refined flow model would provide valuable data on BPA exposure in the Australian 
population. 
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Figure 2a) and log-transformed excretion estimates (ng/kg-d) (see Figure 2b). Regression 
results are presented for the full dataset as well as for the set omitting three extreme values.  
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Table 1: Summary of urinary BPA urinary concentration (total of free and conjugated species), average urinary flow (in ml/kg-d, from flow model); and BPA 
excretion estimate (ng/kg-d) for selected age ranges 
Description Age  (years) 
Av. age 
(years) 
Number 
of pools 
# 
individuals 
per pool 
Av. urinary 
flow 
(ml/kg-d) 
Concentration 
(ng/ml) 
GMa 
Excretion 
(ng/kg-d) 
GMa 
Male >0 – <1 0.36 4   9.10* 713 
Female  0.39 3   1.70 137 
All  0.37 7 7 79.3 4.44 352 
Male ≥1 – <2 1.4 4   6.56* 340 
Female  1.6 3   2.47 123 
All  1.5 7 7 50.8 4.32 219 
Male ≥2 – <3 2.5 5   2.88 107 
Female  2.5 6   2.78 104 
All  2.5 11 7 37.2 2.82 105 
Male ≥3 – <4 3.5 7   2.28 70.6 
Female  3.5 12   2.77 85.8 
All  3.5 19 7 31.0 2.58 79.9 
Male ≥4 – <5 4.5 6   2.18 60.0 
Female  4.5 14   2.93* 80.8 
All  4.5 20 7 27.5 2.67 73.9 
Infants and children       
Male >0 – <5 2.8 26   3.43 134 
Female  3.3 38   2.70 92.3 
All  3.1 64 7 35.9 2.98 107 
Adults        
Male ≥15 – <75 46.4 7   2.98 53.6 
Female  45.4 8   2.32 41.8 
All  45.9 15 28 18.0 2.61 47.0 
 
a geometric mean; *strata contains extreme value 
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Table 2: Regression parameters for log-transformed urinary concentrations (ng/ml) (see Figure 2a) and log-transformed excretion estimates 
(ng/kg-d) (see Figure 2b). Regression results are presented for the full dataset as well as for the set omitting three extreme values.  
 ln(urinary concentration) (ng/ml) ln(excretion estimate) (ng/kg-d) 
 Estimate (SE) 95% CI Best fit  95% CI 
Full data set  
Intercept 1.18 (0.057)* 1.07 to 1.29 4.74 (0.058)* 4.62 to 4.85 
Age (years) -0.0064 (0.0017)* -0.00966 to -0.00315 -0.019 (0.0017)* -0.023 to -0.016 
R2 0.0169 0.128 
Extreme data points omitteda  
Intercept 1.04 (0.053)* 0.93 to 1.14 4.57 (0.053)* 4.47 to 4.68 
Age (years) -0.0036 (0.0015)* -0.0065 to -0.00057 -0.016 (0.0015)* -0.019 to -0.013 
R2 0.00640 0.116 
 
* p<0.05; a Extreme data points identified visually, one in each of the ≥0.5 – <1 year male, ≥1 – <2 year male and ≥4 – <5 year female categories 
at 265, 37.8 and 30.5 ng/ml, respectively. See test for further discussion. 
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Table 3: Summary of studies from literature reporting urinary concentrations of BPA in infants and young children 0-5 years 
Study Country Year of Collection 
BPA concentrationa (ng/mL) N Age (years) Range Mean 
Volkel et al. (2008) Germany 2005 – 2008 <0.3 – 7.5 - 30 5 – 6 
Volkel et al. (2011) Germany 2008 <0.15 – 17.7 <0.45c 91 0.083 – 0.42 
Casas et al. (2011) Spain 2004 – 2008 - 4.2b 30 4 
Morgan et al. (2011) United States 2001 0.4 – 211 4.8 81 2 – 5 
Braun et al. (2011) United States 2004 – 2009 0.4 – 325 3.9 213 1 
   0.4 – 616 2.9 195 2 
   0.4 – 67 2.9 222 3 
This study Australia 2010 – 2011 0.65 – 265 2.97 65d 0 – 5 
 
a total BPA (free + conjugated species); b 10 – 95th percentile; c median; d pooled samples, where each pool contains 7 individual samples 
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Figures 
Figure 1 – Urinary flow model constructed from literature values and normalized to ml/kg-d.  
y=73.43е-6856x+24.17; R2=0.6584 
 
Figure 2 - Linear regression of natural log transformed (a) urinary concentration versus age; 
and (b) daily excretion estimate versus age. For ages 1-<5 each data point represents 7 
individual samples. For ages ≥5-<75 each data point represents 28 individual samples. Data 
presented based on average age of each pool 
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Supplementary Material 
Table S1: Total urinary BPA (free + conjugated) and daily excretion estimates for pooled 
samples from infants and young children 0-5 years 
 
Table S2: Total urinary BPA (free + conjugated) and daily excretion estimates for pooled 
samples from adults ≥15 – <75 years 
 
Table S3: Input values for urine flow model 
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Table S1: Total urinary BPA (free + conjugated) and daily excretion estimates for pooled 
samples from infants and young children 0-5 years 
Sample 
number a 
Age range 
(years) 
Average 
age 
(years) 
BPA 
conc.b 
(ng/ml)  
BPA 
excreted 
(ng/kg-d) 
Males     
1 >0 – <0.5 0.243 2.65 229 
2 >0 – <0.5 0.140 1.93 176 
3 ≥0.5 – <1 0.735 265 18200 
4 ≥0.5 – <1 0.681 5.06 356 
5 ≥1 – <1.5 1.18 37.8 2150 
6 ≥1 – <1.5 1.32 2.96 160 
7 ≥1.5 – <2 1.66 7.98 381 
8 ≥1.5 – <2 1.59 2.08 102 
9 ≥2 – <2.5 2.23 3.27 131 
10 ≥2 – <2.5 2.31 6.64 261 
11 ≥2.5 – <3 2.73 0.78 27.8 
12 ≥2.5 – <3 2.75 2.87 101 
13 ≥2.5 – <3 2.68 4.04 145 
14 ≥3 – <3.5 3.20 5.12 166 
15 ≥3 – <3.5 3.212 1.67 54.0 
16 ≥3 – <3.5 3.32 1.85 58.6 
17 ≥3 – <3.5 3.28 2.55 81.2 
18 ≥3.5 – <4 3.82 1.39 40.9 
19 ≥3.5 – <4 3.74 2.32 69.2 
20 ≥3.5 – <4 3.72 2.43 72.8 
21 ≥4 – <4.5 4.30 2.07 57.9 
22 ≥4 – <4.5 4.29 4.25 119 
23 ≥4 – <4.5 4.28 1.91 53.7 
24 ≥4.5 – <5 4.81 2.22 59.7 
25 ≥4.5 – <5 4.85 2.26 60.6 
26 ≥4.5 – <5 4.65 1.29 35.0 
Females     
27 >0 – <0.5 0.146 0.65 59.2 
28 >0 – <0.5 0.239 2.19 189 
29 ≥0.5 – <1 0.797 3.46 231 
30 ≥1 – <1.5 1.16 1.71 98.1 
31 ≥1.5 – <2 1.88 3.01 134 
32 ≥1.5 – <2 1.66 2.93 140 
33 ≥2 – <2.5 2.23 1.75 70.3 
34 ≥2 – <2.5 2.27 3.74 148 
35 ≥2 – <2.5 2.24 2.44 97.4 
36 ≥2.5 – <3 2.83 1.05 36.5 
37 ≥2.5 – <3 2.78 11.6 408 
38 ≥2.5 – <3 2.81 2.36 82.3 
39 ≥3 – <3.5 3.23 1.47 47.4 
40 ≥3 – <3.5 3.17 3.86 126 
41 ≥3 – <3.5 3.31 1.61 51.2 
42 ≥3 – <3.5 3.24 2.21 71.0 
43 ≥3 – <3.5 3.21 2.53 81.8 
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44 ≥3 – <3.5 3.27 3.05 97.5 
45 ≥3.5 – <4 3.77 0.88 26.2 
46 ≥3.5 – <4 3.76 4.58 136 
47 ≥3.5 – <4 3.74 2.42 72.2 
48 ≥3.5 – <4 3.71 5.57 167 
49 ≥3.5 – <4 3.69 2.44 73.4 
50 ≥3.5 – <4 3.79 9.84 292 
51 ≥4 – <4.5 4.19 2.31 65.4 
52 ≥4 – <4.5 4.22 2.69 75.9 
53 ≥4 – <4.5 4.24 2.26 63.7 
54 ≥4 – <4.5 4.24 2.53 71.4 
55 ≥4 – <4.5 4.23 2.13 60.1 
56 ≥4 – <4.5 4.28 30.5 857 
57 ≥4 – <4.5 4.34 2.43 67.9 
58 ≥4.5 – <5 4.79 3.07 82.7 
59 ≥4.5 – <5 4.76 2.55 68.7 
60 ≥4.5 – <5 4.75 3.09 83.4 
61 ≥4.5 – <5 4.74 3.53 95.4 
62 ≥4.5 – <5 4.74 2.60 70.2 
63 ≥4.5 – <5 4.82 1.89 50.8 
64 ≥4.5 – <5 4.84 1.49 40.0 
 
a Each ‘sample’ is a pooled sample created by systematically combining seven individual 
urine specimens.  
b The concentration of BPA measured in each pool is equivalent to the arithmetic mean of the 
concentration of BPA in each individual sample contributing to the pool 
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Table S2: Total urinary BPA (free + conjugated) and daily excretion estimates for pooled 
samples from adults ≥15 – <75 years 
Sample 
number a 
Age range 
(years) 
Average 
age 
(years) 
BPA 
conc.b 
(ng/ml) 
BPA 
excreted 
(ng/kg-d) 
Males     
1 ≥15 – <30 23.7 9.18 165. 
2 ≥15 – <30 24.3 4.01 72.2 
3 ≥30 – <45 38.3 1.89 34.0 
4 ≥45 – <60 52.7 2.13 38.3 
5 ≥45 – <60 51.8 2.54 45.7 
6 ≥60 – <75 67.1 2.14 38.5 
7 ≥60 – <75 66.9 2.58 46.4 
Females     
8 ≥15 – <30 23.4 2.82 50.8 
9 ≥15 – <30 23.3 4.69 84.4 
10 ≥30 – <45 37.1 2.13 38.3 
11 ≥30 – <45 37.8 1.55 27.9 
12 ≥45 – <60 53.2 4.38 78.8 
13 ≥45 – <60 51.5 1.74 31.3 
14 ≥60 – <75 67.5 2.28 41.0 
15 ≥60 – <75 69.3 1.12 20.2 
 
a Each ‘sample’ is a pooled sample created by systematically combining 28 individual urine 
specimens.  
b The concentration of BPA measured in each pool is equivalent to the arithmetic mean of the 
concentration of BPA in each individual sample contributing to the pool 
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Table S3: Input values for urine flow model 
Age 
(range) 
Age 
(years) 
Study 
participants 
24h 
volume 
(ml) 
Weight 
(kg) 
Flow 
(ml/kg-d) Reference N M F 
30 days 0.0821 5 ●  - - 52 Pratt et al. 
43 days 0.118    - - 81  (1948)a 
50 days 0.137    - - 75  
56 days 0.153    - - 161  
65 days 0.178    - - 91  
0 – 1 months 0.04 11 ● ● - - 106.60 ± 21.80 Goellner et al.
1 – 2 months 0.13    - - 110.70 ± 24.60  (1981) 
2 – 4 months 0.25    - - 85.20 ± 21.50  
4 – 6 months 0.42    - - 73.30 ± 23.40  
6 – 12 months 0.75    - - 74.10 ± 19.40  
12 – 18 months 1.25    - - 80.60 ± 19.90  
18 – 24 months 1.75    - - 66.20 ± 18.90  
24 – 32 months 2.33    - - 61.70 ± 19.90  
7 – 46 days 0.073 6 ●  - - 144.7 ± 7.9 Roberts and 
Lucas 
(1985) 
7 days 0.02 16 ● ● - - 76 ± 17 Magos 
0 – 6 months 0.25 8 ● ● - - 34 ± 6 (1987) 
6 – 12 months 0.75 19 ● ● - - 29 ± 12  
1 – 2 years 1.5 14 ● ● - - 25 ± 7  
2 – 3 years 2.5 6 ● ● - - 33 ± 9  
3 – 4 years 3.5 8 ● ● - - 34 ± 7  
4 – 5 years 4.5 10 ● ● - - 29 ± 10  
6 – 11 years 8.5 21 ● ● - - 22.5 ± 7.7 Ballauff et al. 
(1988) 
4 – 6.9 years 5.45 179 ●  561 21.3 26.34 Ebner and 
Manz 
4 – 6.9 years 5.45 168  ● 537 20.2 26.58 (2002) 
7 – 10.9 years 8.95 163 ●  697 31.6 22.06  
7 – 10.9 years 8.95 158  ● 697 31.2 22.34  
11 – 14.9 years 12.95 104 ●  903 45.8 19.72  
11 – 14.9 years 12.95 101  ● 917 49.2 18.64  
6.2 – 7.6 years 6.9 3b ● ● - - 23 ± 7 Maguire et al. 
 8c ● ● - - 22 ± 6 (2007) 
 18d ● ● - - 22 ± 6  
2 – 4 years 3.66 11 ● ● 398 17.6 22.62 Martins et al. 
(2011) 
6  – <7 years 6.50 157 ● ● - - 34.47 ± 30.32 CDC 
7 – <8 years 7.50 163 ● ● - - 33.25 ± 35.60 (2012) 
8 – <10 years 9.00 349 ● ● - - 29.13 ± 29.90  
10 – <12 years 11.00 354 ● ● - - 25.50 ± 28.60  
12 – <15 years 13.50 427 ● ● - - 20.11 ± 25.90  
 
a only results prior to dietary intervention reported; b optimally fluoridated; c sub-optimally 
fluoridated; d not fluoridated 
 
 
